Comparable Companies and Comparable Transactions
Both apply a multiple; only one already includes control. That difference drives the exam questions.
The market approach values a business by reference to prices paid for similar businesses. ICAI Valuation Standard 103 names three methods: the market price method for a listed share, the Comparable Companies Multiple (CCM) method, also called the guideline public company method, and the Comparable Transaction Multiple (CTM) method, also called the guideline transaction method.
CCM and CTM look alike, since both apply a multiple to a metric of the subject company. They differ in what the multiple already contains, and that difference decides whether you add a control premium or deduct a discount. That is where most exam questions on this topic sit.
You save ₹600
- Full-length mocks
- Case-study practice
- Law module sets
One payment, no subscription · Valid for 2 months
CCM vs CTM at a Glance
Source of the multiple
Comparable companies (CCM)
Traded prices of listed peers in an active market
Comparable transactions (CTM)
Prices paid in M&A deals for similar companies or stakes
What the price reflects
Comparable companies (CCM)
A minority, marketable holding (VS 103 para 45)
Comparable transactions (CTM)
Usually control, as deal prices generally include a control premium (para 30)
Adjustment for a controlling stake
Comparable companies (CCM)
A control premium may be considered
Comparable transactions (CTM)
None needed; already in the price
Adjustment for a minority stake
Comparable companies (CCM)
None for control; DLOM if the subject is unlisted
Comparable transactions (CTM)
A discount for lack of control may be considered (para 46)
Typical data
Comparable companies (CCM)
Exchange prices, annual reports
Comparable transactions (CTM)
Regulatory filings, M&A databases, industry press
| Comparable companies (CCM) | Comparable transactions (CTM) | |
|---|---|---|
| Source of the multiple | Traded prices of listed peers in an active market | Prices paid in M&A deals for similar companies or stakes |
| What the price reflects | A minority, marketable holding (VS 103 para 45) | Usually control, as deal prices generally include a control premium (para 30) |
| Adjustment for a controlling stake | A control premium may be considered | None needed; already in the price |
| Adjustment for a minority stake | None for control; DLOM if the subject is unlisted | A discount for lack of control may be considered (para 46) |
| Typical data | Exchange prices, annual reports | Regulatory filings, M&A databases, industry press |
Building a Multiple
The CCM and CTM steps in VS 103 (paras 22 and 31) are the same in shape.
- 1
Pick comparables
Same industry, geography and line of business, then filter on size, life-cycle stage, profitability and diversification (para 23). Use several, not one (paras 26 and 34).
- 2
Compute the multiples
Price or enterprise value over a financial metric: EBITDA, PAT, sales or book value. Sector multiples such as EV per tower (telecom), EV per tonne (cement), or EV per room (hotels) can be used where market participants use them.
- 3
Adjust for differences
Size, location, profitability, growth, management profile and, for deals, terms such as deferred or contingent consideration (paras 28 and 35).
- 4
Apply and reconcile
Apply the adjusted multiple to the subject's metric. If different metrics give different values, judge the range rather than averaging blindly.
Worked Example: EV/EBITDA
Illustrative. A Pune auto-component maker with EBITDA of ₹50 crore and net debt of ₹120 crore. Three listed peers trade at 8x, 10x and 12x EV/EBITDA.
Selected multiple
Working
Median of 8x, 10x, 12x
₹ crore
10x
Enterprise value
Working
50 × 10
₹ crore
500
Less net debt
Working
500 − 120
₹ crore
380
Equity value (minority, marketable basis)
Working
Before any control or marketability adjustment
₹ crore
380
| Step | Working | ₹ crore |
|---|---|---|
| Selected multiple | Median of 8x, 10x, 12x | 10x |
| Enterprise value | 50 × 10 | 500 |
| Less net debt | 500 − 120 | 380 |
| Equity value (minority, marketable basis) | Before any control or marketability adjustment | 380 |
Quick practice on loss assessment and valuation basics. No signup.
Keep the Numerator and Denominator Consistent
- check_circleEnterprise value multiples (EV/EBITDA, EV/Sales) go with metrics available to all capital providers. The result is enterprise value; deduct debt to reach equity.
- check_circleEquity multiples (P/E, price to book) go with equity metrics such as PAT and net worth. The result is equity value; do not deduct debt again.
- check_circleFor a listed share, the market price method uses an average price over a reasonable period, preferably weighted or volume-weighted, on the exchange where volume is highest (VS 103 paras 18-20), not a single day's close.
- check_circleVS 301 treats a rule of thumb such as a capacity or turnover multiple as a cross-check only: it must not be the only method used.
How the Valuation Examination Tests This
One-mark questions ask which method includes a control premium, or which factor is not a basis for choosing comparables. Case-study questions give a peer table and ask for equity value. The traps: applying a P/E to EBITDA, deducting debt from an equity-multiple result, taking the mean when one peer is an outlier, and adding a control premium to a CTM value that already contains one.
FAQs
What is the difference between comparable company and comparable transaction methods?expand_more
Comparable company multiples come from listed peers' trading prices and reflect a minority, marketable stake. Comparable transaction multiples come from acquisition prices and usually include a control premium.
Why use the median multiple rather than the mean?expand_more
The median is less affected by one peer with an unusually high or low multiple. ICAI VS 103 does not prescribe either; it asks the valuer to use judgement where peers' multiples differ significantly.
Can the market approach be used for an unlisted company?expand_more
Yes. Multiples from listed peers or past deals are applied to the unlisted company's metrics, then adjusted for differences and, where relevant, for lack of marketability.
Next steps
- DCF valuationarrow_forward
- DLOM and controlarrow_forward
- Valuation Approachesarrow_forward
- SFA mock testarrow_forward
Free study material and a free diagnostic test.